Drug Shortage Report for ACT OLMESARTAN HCT

Last updated on 2020-06-11 History
Report ID 61359
Drug Identification Number 02443120
Brand name ACT OLMESARTAN HCT
Common or Proper name OLMESARTAN HCT
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL
Strength(s) 12.5MG 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-09-12
Estimated end date Unknown
Actual end date 2020-06-08
Shortage status Resolved
Updated date 2020-06-11
Company comments Item is discontinued
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-09-12 English Compare
v2 2018-09-12 French Compare
v3 2018-09-13 English Compare
v4 2018-10-11 English Compare
v5 2018-10-11 French Compare
v6 2019-01-08 English Compare
v7 2019-01-08 French Compare
v8 2020-06-11 English Compare
v9 2020-06-11 French Compare

Showing 1 to 9 of 9